Nodular Lymphocyte-Predominant Hodgkin Lymphoma with Splenic and Multiple Bone Involvement: Case Report
Journal: International Research Journal of Pharmacy and Medical Sciences (IRJPMS) (Vol.7, No. 2)Publication Date: 2024-02-15
Abstract
Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL), accounting only for 5% of all HL cases, presents as a diagnostic challenge due to its rare occurrence and diverse morphological features. The malignant lymphocyte predominant (LP) cells in NLPHL are positive for CD20 but lack CD30 and CD15, in contrast to the disease-defining Hodgkin and Reed-Sternberg (H-RS) cells in classical Hodgkin lymphoma (cHL). We report a rare instance of NLPHL stage IV B with spleen and multiple bone involvement in a young patient, diagnosed based on lymph node biopsy and PET/CECT. Furthermore, this case emphasizes the successful application of the R-CHOP regimen in the management of advanced NLPHL, highlighting its potential as a viable therapeutic strategy.
Other Latest Articles
- Exploring Herbal Remedies for Diabetes Management: A Comprehensive Review of Efficacy, Epidemiology, and Quality of Life Considerations
- Using Fig Leaves for Hair Treatment
- Neuroprotective Effects of Annona Muricata Ethanolic Leaf Extract on CyclophosphamideInduced Neurotoxicity in the Cerebral Cortex Using Wistar Rats
- A Comparison of the Safety and Efficacy of Sotagliflozin and Baxaglifloxin in the Treatment of Type II Diabetes Mellites. A systemic review and Meta-analysis
- The Liquid Technique: A Novel Approach to Improve the Solubility and Bioavailability of Insoluble Drugs
Last modified: 2024-04-23 15:34:05